miR 199a 3p - Heqet Therapeutics
Alternative Names: MicroRNA-199a-3p - Heqet Therapeutics; miR-199a-3p - Heqet TherapeuticsLatest Information Update: 21 Dec 2023
At a glance
- Originator Heqet Therapeutics
- Class Anti-ischaemics; MicroRNAs
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Myocardial infarction
Most Recent Events
- 04 Dec 2023 Preclinical studies in Myocardial infarction in Italy (Parenteral) prior to December 2023 (Heqet Therapeutics pipeline; December 2023)